Mucosal proteins

Mucosal proteins are a heterogeneous group of proteins, primarily glycoproteins such as mucins, that constitute the protective mucus layer covering epithelial surfaces in the respiratory, gastrointestinal, and urogenital tracts [2.3.1, 2.4.1]. These proteins serve as a critical component of the innate immune system, providing a physical and chemical barrier that traps pathogens and environmental particles while lubricating the tissue surface [2.3.1, 2.4.2]. In clinical pharmacology, mucosal proteins are often discussed as a collective target for cytoprotective agents like bismuth salts and sucralfate, which cross-link with these proteins to form a protective physical barrier over ulcers and lesions [2.2.1, 2.2.2]. Additionally, specific mucosal proteins like mucins are the primary targets of mucoactive drugs, such as N-acetylcysteine, which modify the structure of these proteins to reduce mucus viscosity in chronic airway diseases [2.4.1]. Because the term refers to a broad class of proteins rather than a single molecular entity, it is generally considered a functional category in drug discovery rather than a specific molecular target [2.1.1, 2.3.3].

Other names

Mucus proteinsMucosal defense factorsMucosal barrier proteinsMucinsMucosal defense proteins

Cytoprotective agents like bismuth and sucralfate bind to mucosal proteins to form a physical barrier over lesions; mucolytics like N-acetylcysteine reduce the viscosity of mucosal proteins (mucins) by breaking disulfide bonds; 5-ASA enhances the expression of mucosal proteins to support barrier integrity [2.2.1, 2.2.2, 2.2.3, 2.4.1].